000 | 01827 a2200517 4500 | ||
---|---|---|---|
005 | 20250516173647.0 | ||
264 | 0 | _c20140226 | |
008 | 201402s 0 0 eng d | ||
022 | _a1879-1891 | ||
024 | 7 |
_a10.1016/j.ajo.2013.08.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTan, Mei Hong | |
245 | 0 | 0 |
_aRandomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion. _h[electronic resource] |
260 |
_bAmerican journal of ophthalmology _cJan 2014 |
||
300 |
_a237-247.e1 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadverse effects |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescein Angiography |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 | _aLaser Coagulation |
650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRanibizumab |
650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
650 | 0 | 4 | _aTomography, Optical Coherence |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aMcAllister, Ian L | |
700 | 1 | _aGillies, Mark E | |
700 | 1 | _aVerma, Nitin | |
700 | 1 | _aBanerjee, Gayatri | |
700 | 1 | _aSmithies, Lynne A | |
700 | 1 | _aWong, Wan-Ling | |
700 | 1 | _aWong, Tien Y | |
773 | 0 |
_tAmerican journal of ophthalmology _gvol. 157 _gno. 1 _gp. 237-247.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2013.08.013 _zAvailable from publisher's website |
999 |
_c23158689 _d23158689 |